SCHEMBL3222902

SCHEMBL3222902

COc1ccc(OC)c(/C=C/C(=O)CC(=O)/C=C/c2ccc(OC)c(O)c2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.74
APP P05067 5/20 0.74
BACE1 P56817 15/20 0.70
MEN1 O00255 2/20 0.67
ALDH1A1 P00352 2/20 0.67
THRB P10828 2/20 0.67
KMT2A Q03164 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
CYP2D6 P10635 2/20 0.61
CYP2C9 P11712 2/20 0.61
TSHR P16473 2/20 0.61
HSD17B10 Q99714 2/20 0.61
JUN P05412 2/20 0.61
NFKB1 P19838 2/20 0.61
CYP2C19 P33261 1/20 0.61
KDM4E B2RXH2 1/20 0.61
PTGES O14684 1/20 0.61
HDAC3 O15379 1/20 0.61
CA12 O43570 1/20 0.61
DYRK3 O43781 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222924 1.00 MAPT (0.74) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3198133 0.94 MAPT (0.84) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3198153 0.94 MAPT (0.84) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3209138 0.91 APP (0.88) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3209158 0.91 APP (0.88) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3217242 0.91 BACE1 (0.82) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3200740 0.91 BACE1 (0.80) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3217230 0.91 BACE1 (0.82) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3200717 0.91 BACE1 (0.80) MAPTAPPBACE1MEN1ALDH1A1
SCHEMBL3209191 0.90 MAPT (0.74) MAPTAPPBACE1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 MAPT 8/4885APP 2/4885BACE1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.